Hepacivirus

10 registered clinical trials studyying Hepacivirus.

Status	Trial	Sponsor	Phase
Unknown	Observational Study of the Interaction Between Hepatitis C Virus Infection and Pregnancy NCT05929963	Beijing Ditan Hospital	—
Unknown	Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients NCT02008214	Centro Universitario de Ciencias de la Salud, Mexico	Phase 4
Terminated	Three-year Follow-up of Participants After Administration of Boceprevir or Narlaprevir for the Treatment of Ch NCT00689390	Merck Sharp & Dohme LLC	Phase 2 / Phase 3
Completed	Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin NCT00705666	Merck Sharp & Dohme LLC	—
Terminated	Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects NCT00687544	Merck Sharp & Dohme LLC	Phase 4
Completed	Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED) NCT00705263	Schering-Plough	—
Completed	Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support NCT00723892	Merck Sharp & Dohme LLC	—
Completed	Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance NCT00704522	Merck Sharp & Dohme LLC	—
Terminated	Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance NCT00723879	Merck Sharp & Dohme LLC	—
Completed	Retrovirus Epidemiology Donor Study-II (REDS-II) NCT00097006	National Heart, Lung, and Blood Institute (NHLBI)	—